Nature Communications (Jan 2022)
Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong
Abstract
Adverse events resulting from COVID-19 vaccination are a public health concern and it is not known whether pre-existing conditions may impose an increased risk. Here, using electronic health records from Hong Kong, the authors show that adverse events are rare for all groups, and there is no evidence of risk modification due to multimorbidity.